NSRX Nasus Pharma Ltd.
Company Analysis
Latest News
🔴 Nasus Pharma is trading 5% down today amid broader healthcare-sector weakness
Nasus Pharma is trading 5.49% down at $3.53, with no clear company-specific negative announcement emerging on September 8, 2026; the decline appears primarily...
🟢 Nasus Pharma is trading 7.33% up in after-hours trading with no confirmed catalyst
Nasus Pharma is trading 7.33% higher at $3.73 in after-hours trading, with no confirmed catalyst. - It closed at $3.53 on September 4, 2026. - No new...
🔴 Nasus Pharma is trading 5.9% down today
Nasus Pharma is trading at $3.53, down -5.88% after opening-session weakness on September 4, 2026. - No new company-specific announcement dated September 4...
🔴 Nasus Pharma is trading 10.1% down today with catalyst unclear
Nasus Pharma is trading 10.1% down at $3.39 after opening-session weakness on September 3, 2026; the catalyst remains unclear. - No new company-specific...
🔴 Nasus Pharma is trading 6.76% down today; no new company-specific announcement identified
Nasus Pharma is trading 6.76% down at $3.52, with no new company-specific announcement dated September 3, 2026 identified. - The stock is weaker after closing...
🟢 Nasus Pharma is trading 5.54% up today amid Healthcare's 1.37% gain
Nasus Pharma is trading 5.54% up at $4.04, with the move appearing primarily sector-driven as Healthcare rises 1.37% alongside a rebound from the prior...
🔴 Nasus Pharma is trading 14.05% down today amid renewed U.S.-Iran tensions
Nasus Pharma is trading 14.05% down at $3.51 after no confirmed company-specific announcement dated September 1, 2026 emerged; the decline appears tied to...
🔴 Nasus Pharma is trading 5.73% down today amid global risk-off pressure
Nasus Pharma is trading 5.73% down now at $3.85 amid global risk-off pressure, including rising rates and geopolitical concerns. - The S&P 500 is down 0.61%,...
🔴 Nasus Pharma is trading 5.6% down today — no confirmed same-day catalyst
Nasus Pharma is trading 5.61% down at $3.87, with no new announcement dated August 31, 2026, or reliable report explicitly explaining the decline. - Latest...
🔴 Nasus Pharma is trading 5.6% down today
Nasus Pharma is trading 5.6% down at $3.87, based on the provided live price; no company announcement dated August 26, 2026, or source-confirmed catalyst...
🔴 Nasus Pharma is trading 5.9% down today as Nasdaq Composite falls amid elevated Treasury yields
Nasus Pharma is trading 5.9% down at $3.77 amid a broadly weaker market. - The Nasdaq Composite is down 0.68%, with risk assets pressured by elevated Treasury...
Nasus Pharma Secures SEC Approval, Clearing Path for Clinical Trial Funding
Nasus Pharma Ltd. received a Notice of Effectiveness from the U.S. Securities and Exchange Commission on August 21, 2026. This regulatory milestone confirms...
🔴 Nasus Pharma Ltd. is trading 5.06% down
NSRX is trading at $3.65, down 5.06%.
🔴 Nasus Pharma is trading 8.6% down today after CFO Eyal Rubin announces departure
Nasus Pharma is trading 8.59% down now at $3.51 after announcing on August 19, 2026, that CFO Eyal Rubin will leave for an opportunity outside the life-science...
🔴 Nasus Pharma is trading 6.66% down in pre-market after CFO Eyal Rubin's departure announcement
Nasus Pharma is trading 6.66% down in pre-market at $3.58 after announcing that CFO Eyal Rubin will leave for a new opportunity outside the life-science...
🟢 Nasus Pharma is trading 10.66% up today in after-hours trading after strong first-half 2026 financial results
Nasus Pharma is trading 10.66% up at $3.84 in after-hours trading, likely driven by the positive first-half 2026 financial results released on August 17,...
🟢 Nasus Pharma rises 5.2% — Healthcare Stocks Surge on Strong Earnings Outlook and Investor Rotation
With Healthcare (XLV) up 3.2%, this looks like a sector-led move rather than a company-specific surprise. The healthcare sector experienced a significant...
🔴 Nasus Pharma is trading 5% down today after first-half net loss widened to $5.9 million
Nasus Pharma is trading at $3.46, down 5.08%, after investors reacted to its August 17, 2026 first-half results and business update, which showed net loss...
🔴 Nasus Pharma is trading 5% down in pre-market after first-half loss widened
Nasus Pharma is trading 5.21% down now at $3.46 after investors reacted to its August 17 first-half results and business update. - Reported a $5.94 million...
Nasus Pharma's Loss Balloons as Cash Clock Ticks — Can a Nasal Spray Bet Justify the Burn?
Shares of Nasus Pharma (NSRX) slid 9% to $3.37 after the Tel Aviv-based clinical-stage biotech reported first-half results that spooked investors with a...